MODULATION OF ALLOIMMUNE RESPONSE BY CANINE MARROW-CELLS

MODULATION OF ALLOIMMUNE RESPONSE BY CANINE MARROW-CELLS

Detalhes bibliográficos
Main Authors:	Gunther, W, Schumm, M, Voss, C, Kremmer, E, Cobbold, S, Thierfelder, S, Wilmanns, W, Kolb, H
Formato:	Journal article
Publicado em:	1995

Registos relacionados

INVITRO TREATMENT OF MARROW WITH ATCG OR CAMPATH-1 FOR PROPHYLAXIS OF GVHD - RESULTS OF THE AG-KMT MUNCHEN
Por: Kolb, H, et al.
Publicado em: (1985)

Prostanoids modulate inflammation and alloimmune responses during graft rejection
Por: P.N. Rocha, et al.
Publicado em: (2005-12-01)

Antilymphocytic antibodies and marrow transplantation. VII. Two of nine monoclonal anti-Thy-1 antibodies used for pretreatment of donor marrow suppressed graft-versus-host reactions without added complement.
Por: Thierfelder, S, et al.
Publicado em: (1985)

Regulation of the Alloimmune Response
Por: Wood, K, et al.
Publicado em: (2012)

Modulation of alloimmunity by Heat shock proteins
Por: Thiago J Borges, et al.
Publicado em: (2016-08-01)

Altered heme-mediated modulation of dendritic cell function in sickle cell alloimmunization
Por: Emmanuelle Godefroy, et al.
Publicado em: (2016-09-01)

Mechanisms of Alloimmune Tolerance Associated with Mixed Chimerism Induced by Vascularized Bone Marrow Transplants
Por: Rajen Ramsamooj, et al.
Publicado em: (2002-10-01)

Aloimunização em pacientes com insuficiência medular Alloimmunization in bone marrow failure
Por: Silvia M. M. Magalhães
Publicado em: (2008-02-01)

Alloimmune Responses of Humanized Mice to Human Pluripotent Stem Cell Therapeutics
Por: Nigel G. Kooreman, et al.
Publicado em: (2017-08-01)

Red cell alloimmunization in repeatedly transfused patients
Por: Dimel K Bhuva, et al.
Publicado em: (2017-01-01)

DIFFERENTIAL EXPRESSION OF TLR-2 AND CTLA-4 BETWEEN ALLOIMMUNIZED AND NON-ALLOIMMUNIZED INDIVIDUALS WITH SICKLE CELL DISEASE
Por: V.B. Oliveira, et al.
Publicado em: (2020-11-01)

ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA USING CAMPATH-1 MONOCLONAL-ANTIBODIES AND POSTTRANSPLANT ALLOIMMUNIZATION WITH DONOR LYMPHOCYTES
Por: Naparstek, E, et al.
Publicado em: (1993)

Red cell transfusion and alloimmunization in sickle cell disease
Por: Grace E. Linder, et al.
Publicado em: (2021-04-01)

Role of the Liver in Alloimmune Response following Inoculation of Donor Spleen Cells
Por: Li He, et al.
Publicado em: (2000-09-01)

Neonatal Alloimmune Thrombocytopenia
Por: Melike Sezgin Evim, et al.
Publicado em: (2011-08-01)

Neonatal alloimmune thrombocytopenia
Por: Cécile Kaplan
Publicado em: (2008-06-01)

Alloimmunization in thalassemia patients
Por: Beuy Joob, et al.
Publicado em: (2019-01-01)

Mesenchymal Stromal Cells Modulate Corneal Alloimmunity via Secretion of Hepatocyte Growth Factor
Por: Sharad K. Mittal, et al.
Publicado em: (2019-10-01)

Grand challenges in alloimmunity and transplantation
Por: Antoine eToubert
Publicado em: (2011-08-01)

Fetal alloimmune thrombocytopenia and maternal intravenous immunoglobulin infusion
Por: Günther Giers, et al.
Publicado em: (2010-11-01)

Immunosuppression with monoclonal antibodies. A model to determine the rules for effective serotherapy.
Por: Cobbold, S, et al.
Publicado em: (1983)

Intercellular transfer of MHC molecules in T cell alloimmunity and allotransplantation
Por: Gilles Benichou, et al.
Publicado em: (2024-10-01)

Red cell alloimmunization in chronic kidney disease
Por: Suvro Sankha Datta
Publicado em: (2024-12-01)

Altered type 1 interferon responses in alloimmunized and nonalloimmunized patients with sickle cell disease
Por: Emaan Madany, et al.
Publicado em: (2021-11-01)

Selective blockade of CD28 on human T cells facilitates regulation of alloimmune responses
Por: Zaitsu, M, et al.
Publicado em: (2017)

Monoclonals and marrow transplants.
Por: Waldmann, H, et al.
Publicado em: (1986)

Alloimmunization in Transfusion Dependent Thalassaemic Patients.
Por: Saad H. Ahmed, et al.
Publicado em: (2010-04-01)

Bone marrow stem cell applied in the canine veterinary clinics
Por: Ingrid S. Gomes, et al.

Modulation of Alloimmune Responses by Interleukin-10 Prevents Rejection of Implanted Allogeneic Smooth Muscle Cells and Restores Postinfarction Ventricular Function
Por: Sanjiv Dhingra, et al.
Publicado em: (2015-06-01)

Advances in the management of alloimmune thrombocytopenia.
Por: Murphy, M, et al.
Publicado em: (2007)

Neonatal and fetal alloimmune thrombocytopenia
Por: Ioana Emanuela Atanasescu, et al.
Publicado em: (2022-06-01)

Foetal and neonatal alloimmune thrombocytopaenia
Por: Kaplan Cecile
Publicado em: (2006-10-01)

March1-dependent modulation of donor MHC II on CD103+ dendritic cells mitigates alloimmunity
Por: Thiago J. Borges, et al.
Publicado em: (2018-08-01)

MONOCLONAL-ANTIBODY SUPPRESSION OF GRAFT-VS-HOST REACTION WITHOUT THE NEED FOR COMPLEMENT OR RICIN
Por: Okunewick, J, et al.
Publicado em: (1984)

Red Cell Alloimmunization in Repeatedly Transfused Cancer Patients
Por: Shahida Mohsin
Publicado em: (2013-12-01)

Risk factors for alloimmunization by patients with sickle cell disease
Por: M. Murao, et al.
Publicado em: (2005-05-01)

Benefit of Belatacept in Cord Blood-Derived Regulatory T Cell-Mediated Suppression of Alloimmune Response
Por: Xing He, et al.
Publicado em: (2021-09-01)

Genetic variations in T-cell activation and effector pathways modulate alloimmune responses after allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies
Por: Haowen Xiao, et al.
Publicado em: (2012-12-01)

T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation.
Por: Hale, G, et al.
Publicado em: (1988)

The Association of CD81 Polymorphisms with Alloimmunization in Sickle Cell Disease
Por: Zohreh Tatari-Calderone, et al.
Publicado em: (2013-01-01)